| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.31B | 29.77B | 32.65B | 32.27B | 27.16B | 27.71B |
| Gross Profit | 5.30B | 5.38B | 5.78B | 4.78B | 4.15B | 4.30B |
| EBITDA | 2.61B | 2.83B | 3.17B | 2.40B | 1.95B | 2.11B |
| Net Income | 1.35B | 1.84B | 1.79B | 1.59B | 1.28B | 1.37B |
Balance Sheet | ||||||
| Total Assets | 27.58B | 31.81B | 30.60B | 33.53B | 29.36B | 27.47B |
| Cash, Cash Equivalents and Short-Term Investments | 8.45B | 8.27B | 7.99B | 8.76B | 8.35B | 8.24B |
| Total Debt | 305.00M | 408.60M | 566.15M | 1.02B | 1.01B | 1.08B |
| Total Liabilities | 8.66B | 11.16B | 11.62B | 15.75B | 12.92B | 11.95B |
| Stockholders Equity | 18.92B | 20.65B | 18.98B | 17.78B | 16.44B | 15.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.88B | 695.13M | 1.88B | 1.16B | 676.98M |
| Operating Cash Flow | 0.00 | 2.04B | 1.13B | 1.98B | 1.32B | 965.19M |
| Investing Cash Flow | 0.00 | -1.02B | -839.99M | -1.09B | -802.87M | -1.10B |
| Financing Cash Flow | 0.00 | -755.08M | -1.11B | -486.81M | -446.03M | -263.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥15.69B | 10.00 | ― | 3.71% | -8.81% | 2.81% | |
77 Outperform | ¥23.81B | 7.75 | ― | 2.37% | 2.65% | 7.45% | |
74 Outperform | ¥23.05B | 7.32 | ― | 2.97% | -9.99% | 58.24% | |
73 Outperform | ¥77.96B | 12.54 | ― | 1.25% | 4.37% | 6.30% | |
70 Outperform | ¥4.40B | 2.29 | ― | 1.16% | 36.36% | 155.68% | |
65 Neutral | ¥14.57B | 7.54 | ― | 3.68% | -9.66% | 22.05% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |